UBE2L3 and cervical carcinoma: We next evaluated whether doxorubicin, which mediates the nuclear import of HP1γ and UBE2L3 suppression, can reverse cisplatin resistance in SiHa cells that showed the highest IC50 value of cisplatin among the three cervical cancer cell lines (Figure 1B).